Clinical Trials · NCT02788747
Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 71
- Start date
- Jun 2016
- Locations
- 15 sites, 3 countries
- Primary endpoint
- Change in Left Ventricular End Systolic Volume (ml)